BillionToOne Launches Unity Confirm™: A Non-Invasive Prenatal Diagnostic Test
BillionToOne has launched Unity Confirm™, a non-invasive prenatal test that captures intact circulating fetal cells to confirm high-risk screening results. The test aims to bridge the gap between prenatal screening and invasive diagnostics, providing rapid insights from a single maternal blood draw. Unity Confirm has shown 100% concordance with known fetal outcomes and is designed to make prenatal care more accessible and less risky for patients.
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture™ Technology MENLO PARK, Calif., May 1, 2026 /PRNewswire/ — For more than two…